Skip to main content

Table 4 Static compliance and clinical course of the SARS-CoV-2 infection

From: Detection of residual pulmonary alterations with lung ultrasound and effects on postoperative pulmonary complications for patients with asymptomatic SARS-CoV-2 infection undergoing surgeries

Compliance

 

<50, n =35

≥50, n =34

p-value

Covid19-Surgery

101.34 ± 73.16

135.03 ± 92.80

0.14

Hospitalization days

5.03 ± 14.87

5.82 ± 9.70

0.24

ICU days

2.52 ± 9.30

1.29 ± 5.39

0.32

NIMV days

0.94 ± 2.89

0.35 ± 1.25

0.64

IMV days

1.51 ± 7.83

0.74 ± 4.29

0.57

Cough

13 (37.1)

13 (38.2)

0.92

Dyspnea

9 (25.7)

12 (35.3)

0.38

Fever

11 (31.4)

18 (52.9)

0.07

Digestive disorders

9 (25.7)

9 (26.5)

0.94

Pneumonia

12 (34.3)

15 (44.1)

0.40

Venous thrombosis

1 (2.9)

0 (0)

0.32

PTE

1 (2.9)

0 (0)

0.32

ARDS

2 (5.7)

1 (2.9)

0.57

Vasoactive drugs

3 (8.6)

0 (0)

0.08

  1. COVID-19-Surgery: Days elapsed from diagnosis of SARS-CoV-2 infection to the day of surgery. ICU Intensive Care Unit. NIMV Non-invasive mechanical ventilation, IMV Invasive mechanical ventilation, PTE Pulmonary thromboembolism, ARDS Acute respiratory distress syndrome. Data are expressed as mean ± SD, and number (percentage)
Back to article page

BMC Anesthesiology

ISSN: 1471-2253

Contact us